Publication bias: What are the challenges and can they be overcome?

Journal of Psychiatry and Neuroscience

Volumn 37, Issue 3, 2012, Pages 149-152

  Joober, Ridha ^a   Schmitz, Norbert ^b   Annable, Lawrence ^b   Boksa, Patricia ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

AUTISM; CAREER PLANNING; CLINICAL TRIAL (TOPIC); DEPRESSION; DRUG EFFICACY; DRUG SAFETY; ECONOMIC ASPECT; EDITOR; EDITORIAL; FUNDING; HUMAN; JOURNAL IMPACT FACTOR; MEDICAL LITERATURE; MEDICAL RESEARCH; META ANALYSIS (TOPIC); OXIDATIVE STRESS; PROBABILITY; PUBLISHING; SAMPLE SIZE; SCIENTIST; STATISTICAL ANALYSIS;

EID: 84860512109     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.120065     Document Type: Editorial

References (15)

1. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-260.
2. Barbui C, Furukawa TA, Cipriani A. Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials. CMAJ 2008;178:296-305.
3. Eyding D, Lelgemann M, Grouven U, et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin re -uptake inhibitor controlled trials. BMJ 2010;341:c4737.
4. Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin re-uptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341-1315.
5. Ioannidis JP. Effectiveness of antidepressants: An evidence myth constructed from a thousand randomized trials? Philos Ethics Humanit Med 2008;3:14.
6. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-260.
7. Fanelli D. Negative results are disappearing from most disciplines and countries. Scientometrics 2012;90:891-904.
8. Rossignol DA, Frye RE. A review of research trends in physiologic al abnormalities in autism spectrum disorders: immune dys-regulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry 2012; 17:389-401.
9. Ioannidis JP. An epidemic of false claims. Competition and conflicts of interest distort too many medical findings. Sci Am 2011; 304:16.
10. Munafò MR, Attwood AS, Flint J. Bias in genetic association studies: effects of research location and resources. Psychol Med 2008; 38: 1213-1214.
11. Munafò MR, Stothart G, Flint J. Bias in genetic association studies and impact factor. Mol Psychiatry 2009;14:119-120.
12. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124.
13. Ioannidis JP, Tarone R, McLaughlin JK. The false-positive to false-negative ratio in epidemiologic studies. Epidemiology 2011;22:450-456.
14. Huic M, Marusic M, Marusic A. Completeness and changes in registered data and reporting bias of randomized controlled trials in ICMJE journals after trial registration policy. PLoS ONE 2011;6: e25258.
15. Jakobsen AK, Christensen R, Persson R, et al. Open access publishing. And now, e-publication bias. BMJ 2010;340:c2243.